C3.ai(US:AI) Prnewswireยท2025-10-09 12:45Core Viewpoint - C3.ai, Inc. is facing a class action lawsuit due to allegations of providing misleading statements about its growth and the impact of its CEO's health on the company's performance, leading to a significant drop in stock price following disappointing financial results [1][2]. Summary by Sections Allegations - The complaint claims that C3.ai's management made overly positive statements while concealing material adverse facts about the company's growth, particularly regarding the CEO's health affecting deal closures and overall performance [1]. - On August 8, 2025, C3.ai announced disappointing preliminary financial results for Q1 of fiscal 2026 and reduced its revenue guidance for the full fiscal year 2026, attributing these issues to "the reorganization with new leadership" and the CEO's health problems [1]. Stock Price Impact - Following the announcement of poor financial results, C3.ai's stock price fell from $22.13 per share on August 8, 2025, to $16.47 per share on August 11, 2025, marking a decline of approximately 25.58% in just one day [1]. Class Action Details - Shareholders who purchased shares during the specified class period (February 26, 2025, to August 8, 2025) are encouraged to register for the class action, with a deadline for lead plaintiff appointment set for October 21, 2025 [2]. - Registered shareholders will receive updates through a portfolio monitoring software throughout the lifecycle of the case, with no cost or obligation to participate [2]. Law Firm Background - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting investors' rights against deceit and fraud, aiming to ensure companies adhere to responsible business practices [3].